Thank you, Lee. Good morning everyone and thank you for joining us. For the second quarter, revenue decreased 36% to $68 million from $106.1 million in the prior year quarter. Biofuels revenue decreased 45% to $35.4 million. We experienced biodiesel sales volumes with a lower average selling price. Chemical revenues decreased 22% to $32.6 million. Revenues decreased primarily on sales volumes for the following: our bleach activator was down 19%, proprietary herbicide intermediates was down 51%, antimicrobial intermediates and other custom products was down 38%. Partially offsetting these decreases was increased sales volumes from other performance chemicals of 33% from an existing product line and from a new product, and DIPB and CPOs were up 7%. Within the other custom chem product portfolio, we lost sales of a product to a substantial customer that was sold on a purchase order basis and we had reduced sales volumes from discontinued production of another custom chemical product due to lack of demand. We also experienced reduced sales of a product due to timing of shipments. Gross profit for the second quarter decreased 76% to $6.6 million from $27.6 million. Biofuels gross profit decreased to a loss of $0.6 million as compared to income of $12.8 million in the second quarter of 2013. This difference resulted from, one, severely weakened marketing conditions for biodiesel largely as a result of the absence of the dollar blender’s credit and the absence of a final mandate from the EPA for the 2014 RVO. Secondly, impacting it was the inventor of unsold internally generated RINs. We do not allocate production costs to internally-generated RINs, and from time to time we enter into sales of biodiesel on a RINs-free basis. We had minimal RINs at June 30, 2013. Thirdly, we had hedging losses this quarter of $0.3 million as compared to hedging gains of $2.3 million in the prior year period. Fourthly, partially offsetting these reductions in gross profit was a shift of fixed costs to chemicals during the quarter. Chemical segment gross profit decreased 52% to $7.1 million. The reduction in gross profit was primarily attributed to the change in sales volumes and the shift to fixed costs, as previously mentioned. In addition, the reduction was somewhat attributed to yield losses which are being resolved but did slow our production and sales volume. To a lesser extent, higher raw material costs were incurred during the quarter, part of which will be recovered in the third quarter. Earnings from operations decreased 83% to $4.2 million. Net income totaled $5.3 million for the second quarter of 2014 or $0.12 per diluted share. This compares against $18.2 million for the second quarter of 2013 or $0.42 per diluted share. For the six months ended June 30, 2014, revenues decreased 24% to $150.2 million as compared to $198.2 million in the first half of 2013. Biofuels revenue decreased 25% to $87.4 million. Gallons sold decreased, as did the average selling price of V100 given weak biodiesel market conditions. Revenues from chemical sales decreased 23% to $62.9 million. Revenues for each product line changed as follows and were primarily attributed to reduced sales volumes: the bleach activator decreased 21%, proprietary herbicide intermediate decreased 57%, other custom chemicals, including the antimicrobial industrial intermediate decreased 37%. Slightly offsetting these decreases was a 12% increase in revenue for CPOs and DIPB and a 30% increase in revenue from performance chemicals from a new product. Gross profit for the first half of 2014 was $16.2 million, down from $49 million in 2013. Gross profit for biodiesel decreased 74% to $15,000 for the six months ended June 30, 2014 as compared to $43.9 million in the same period of 2013. The significant reduction was largely the result of a combination of the following: the expiration of the dollar per gallon blender’s tax credit on December 31, 2013; the first six months of 2013 included the benefit of the retroactive reinstatement of the 2012 blender’s tax credit of $2.5 million. We also had hedging losses which totaled $294,000 in the first six months of 2014 as compared to hedging gains of $3.7 million in the same period of 2013; and last, the establishment of an inventory of biodiesel RINs at June 30, 2014 when no such inventory was present in the prior year. Chemical gross profit decreased 42% to $16.2 million, down from $27.9 million in 2013. This reduction was largely the result of reduced sales volumes, particularly for again the proprietary herbicide intermediate, two other custom chemicals we no longer sell, the bleach activator, and the timing of shipments of a product we sell. Also impacting gross profit was lower production yields for certain chemicals which are not expected to continue but did delay the quantity of product shipped to our customer. Earnings from operations was $11.6 million in the first half of the year as compared to $43.9 million in the first half of 2013. Net income totaled $11.6 million for the first half of the year or $0.27 per diluted share. This compares against $32.2 million for the first half of 2013 or $0.75 per diluted share. Lee, that concludes my remarks. I’ll turn the call back over to you.